Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonbeta-1b therapy in a patient with childhood-onset multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.44.68PMID 15704667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple sclerosis in children.

  2003cited by this paper
• Interferon-α and Autoimmune Thyroid Disease

  2003cited by this paper
• Interferon-alpha and autoimmune thyroid disease.

  2003cited by this paper
• Contrasting effects of IFNβ and IVIG in children with central and peripheral demyelination

  2003cited by this paper
• Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy

  2002cited by this paper
• Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

  2002cited by this paper
• Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes

  2001cited by this paper
• Chronic inflammatory demyelinating polyneuropathy after treatment with interferon‐α

  2000cited by this paper
• Type I interferons and chronic inflammatory demyelinating polyneuropathy: Treatment or cause?

  2000cited by this paper
• Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.

  1999cited by this paper
• Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-α

  1998cited by this paper
• Multiple sclerosis in childhood: report of 16 cases.

  1996cited by this paper
• Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy.

  1996cited by this paper
• Long term recombinant interferon alpha treatment in MS with special emphasis to side effects

  1996cited by this paper
• Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study

  1995cited by this paper
• Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

  1995cited by this paper
• Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon

  1994cited by this paper
• Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)

  1991cited by this paper
• Central lesions in chronic inflammatory demyelinating polyneuropathy

  1990cited by this paper
• Multiple Sclerosis in Children: Report of Clinical and Paraclinical Features of 19 Cases

  1988cited by this paper
• Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy

  1987cited by this paper
• The peripheral nervous system in multiple sclerosis. A review and pathogenetic hypothesis.

  1987cited by this paper
• A case of childhood multiple sclerosis with peripheral neuropathy.

  1985cited by this paper

• Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?

  2023cites this paper
• Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.

  2019cites this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy

  2018cites this paper
• Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

  2017cites this paper
• Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

  2015cites this paper
• Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

  2013cites this paper
• Anti‐neurofascin antibody in combined central and peripheral demyelination

  2013cites this paper
• Immunomodulation in inflammatory neuropathies: rationale and safety.

  2013cites this paper
• Abnormal Nerve Conduction Study Findings Indicating the Existence of Peripheral Neuropathy in Multiple Sclerosis and Neuromyelitis Optica

  2013cites this paper
• Current immune therapies of autoimmune disease of the nervous system with special emphasis to multiple sclerosis.

  2012cites this paper
• Autoimmune disorders affecting both the central and peripheral nervous system.

  2012cites this paper
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy - An Overview of Existing Treatment Options and Prospects for the Future

  2011cites this paper
• Drug-induced dysimmune demyelinating neuropathies.

  2011cites this paper
• Treatment of Chronic Immune-mediated Neuropathies: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Multifocal Motor Neuropathy, and the Lewis-Sumner Syndrome

  2010cites this paper
• Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

  2010cites this paper
• Recombinant interferon-beta therapy and neuromuscular disorders.

  2009cites this paper
• Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy

  2008cites this paper
• Multiple Sclerosis and Peripheral Multifocal Demyelinating Neuropathies Occurring in a Same Patient

  2008cites this paper
• Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy.

  2008cites this paper
• Simultaneous Guillain-Barré Syndrome and Acute Disseminated Encephalomyelitis in the Pediatric Population

  2008cites this paper
• Relapsing demyelinating disease affecting both the central and peripheral nervous systems

  2008cites this paper
• Patterns and significance of concomitant central and peripheral inflammatory demyelination

  2006cites this paper
• Chronic Inflammatory Demyelinating Polyneuropathy Developed during Interferon-beta Therapy in a Patient with Multiple Sclerosis

  2006cites this paper
• Treatment of Guillain‐Barré syndrome and CIDP

  2005cites this paper
• Treatment of Guillain‐Barré syndrome and CIDP

  2005cites this paper
• Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.

  2004cites this paper